- Home
- DCBO vs RZLT Comparison
DCBO vs RZLT Comparison
Compare DCBO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCBO
- RZLT
- Stock Information
- Founded
- DCBO 2016
- RZLT 2010
- Country
- DCBO Canada
- RZLT United States
- Employees
- DCBO N/A
- RZLT N/A
- Industry
- DCBO
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- DCBO
- RZLT Health Care
- Exchange
- DCBO Nasdaq
- RZLT Nasdaq
- Market Cap
- DCBO 788.2M
- RZLT 713.4M
- IPO Year
- DCBO 2020
- RZLT N/A
- Fundamental
- Price
- DCBO $27.33
- RZLT $8.90
- Analyst Decision
- DCBO Strong Buy
- RZLT Strong Buy
- Analyst Count
- DCBO 6
- RZLT 6
- Target Price
- DCBO $41.33
- RZLT $14.50
- AVG Volume (30 Days)
- DCBO 59.1K
- RZLT 1.5M
- Earning Date
- DCBO 11-07-2025
- RZLT 11-06-2025
- Dividend Yield
- DCBO N/A
- RZLT N/A
- EPS Growth
- DCBO 33.51
- RZLT N/A
- EPS
- DCBO 0.69
- RZLT N/A
- Revenue
- DCBO $230,502,000.00
- RZLT N/A
- Revenue This Year
- DCBO $13.02
- RZLT N/A
- Revenue Next Year
- DCBO $8.37
- RZLT N/A
- P/E Ratio
- DCBO $39.36
- RZLT N/A
- Revenue Growth
- DCBO 15.11
- RZLT N/A
- 52 Week Low
- DCBO $25.50
- RZLT $2.22
- 52 Week High
- DCBO $53.86
- RZLT $9.72
- Technical
- Relative Strength Index (RSI)
- DCBO 33.68
- RZLT 61.89
- Support Level
- DCBO $26.95
- RZLT $8.97
- Resistance Level
- DCBO $28.03
- RZLT $9.72
- Average True Range (ATR)
- DCBO 0.60
- RZLT 0.61
- MACD
- DCBO -0.18
- RZLT -0.04
- Stochastic Oscillator
- DCBO 11.05
- RZLT 66.64
About DCBO Docebo Inc.
Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.